|
Stock Analysis PRO New!
|
|
| Risk Assessment |
|
| Trading Strategy |
|
ZyVersa Therapeutics, Inc. stock upgraded to Hold/Accumulate
(Updated on Nov 17, 2025)
The ZyVersa Therapeutics, Inc. stock price gained 4.95% on the last trading day (Monday, 17th Nov 2025), rising from $0.133 to $0.140. During the last trading day the stock fluctuated 4.95% from a day low at $0.133 to a day high of $0.140. The price has fallen in 5 of the last 10 days and is down by -1.41% for this period. Volume fell on the last day by -115 thousand shares and in total, 5 thousand shares were bought and sold for approximately $728.14 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.41% during the next 3 months and, with a 90% probability hold a price between $0.122 and $0.186 at the end of this 3-month period.
ZVSA Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, November 14, 2025, and so far it has risen 4.95%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The ZyVersa Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.141 and $0.144. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for ZyVersa Therapeutics, Inc. stock
ZyVersa Therapeutics, Inc. finds support from accumulated volume at $0.140 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0066 between high and low, or 4.95%. For the last week the stock has had daily average volatility of 8.60%.
Our recommended stop-loss: $0.135 (-3.68%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)
Trading Expectations (ZVSA) For The Upcoming Trading Day Of Tuesday 18th
For the upcoming trading day on Tuesday, 18th we expect ZyVersa Therapeutics, Inc. to open at $0.138, and during the day (based on 14 day Average True Range), to move between $0.133 and $0.147, which gives a possible trading interval of +/-$0.0131 (+/-9.84%) up or down from last closing price. If ZyVersa Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 9.84% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.140 (0.14%) than the resistance at $0.146 (4.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
ZyVersa Therapeutics, Inc. will release earnings BMO on Thursday, November 20, 2025. We will update the financials statements for ZyVersa Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.60% in the first trading day after earnings release.
Is ZyVersa Therapeutics, Inc. stock A Buy?
ZyVersa Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
-0.467
Hold/Accumulate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on November 18, 2025 - $0.138 ( 1.57%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ZVSA Performance
Trading levels for ZVSA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.144 | 3.14% |
| R2 | 0.142 | 1.34% |
| R1 | 0.140 | 0.229% |
| Price | 0.140 | |
| S1 | 0.135 | -3.37% |
| S2 | 0.134 | -4.48% |
| S3 | 0.131 | -6.29% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.160 | 14.29% |
| R2 | 0.150 | 7.14% |
| R1 | 0.146 | 4.29% |
| Price | 0.140 | |
| S1 | 0.140 | -0.143% |
| S2 | 0.133 | -4.71% |
| S3 | 0.130 | -7.14% |
FAQ
Click here for our free guide on how to buy ZyVersa Therapeutics, Inc. Stock.
Buy ZVSA
A sell signal from a double top formation was found on Thursday, September 25, 2025 with a target of $0.146. Despite whether the objective of the signal formation has been reached the stock may continue to fall.